InGel Therapeutics is Harvard-spinoff, regenerative medicine biotech leveraging novel neuroprotective mechanisms to stop retinal degeneration. Our beachhead indication is Retinitis Pigmentosa, with future expansion opportunities which include Dry-AMD and Glaucoma.
Company Details
- Employees
- 8
- Founded
- -
- Address
- Boston, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.ingeltx.com
- HQ
- Boston
Ingel Therapeutics, Inc. Questions
Ingel Therapeutics, Inc.'s website is http://www.ingeltx.com
Ingel Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/ingel-therapeutics
Ingel Therapeutics, Inc. has
8 employees.
View email and phone details for 8
employees at Ingel Therapeutics, Inc..
Ingel Therapeutics, Inc.'s industry is
Biotechnology Research
Ingel Therapeutics, Inc.'s top competitors are
Modulate Bio,
Paratus Sciences,
Marinus Pharma,
Ilios Therapeutics,
Acousticabio,
Nucleate,
Advanced Research Projects Agency For Health (Arpa-H),
Lybra Bio,
Neoclease,
Onl Therapeutics.
Ingel Therapeutics, Inc.'s categories are Biotechnology Research
Ingel Therapeutics, Inc.'s founding year is 2022
